"10.1371_journal.pone.0148762","plos one","2016-02-24T00:00:00Z","Joseph A Newman; Christopher D O Cooper; Anette K Roos; Hazel Aitkenhead; Udo C T Oppermann; Hearn J Cho; Roman Osman; Opher Gileadi","Structural Genomics Consortium, University of Oxford, ORCRB, Roosevelt Drive, Oxford, OX3 7DQ, United Kingdom; NDORMS, University of Oxford, Botnar Research Centre, Oxford, OX3 7LD, United Kingdom; Tisch Cancer Institute, Mt Sinai School of Medicine, Icahn 15-20B 1425 Madison Avenue, New York, NY, 10029, United States of America; Department of Structural and Chemical Biology, Box 1677, Mount Sinai School of Medicine, New York, NY, 10029, United States of America","Conceived and designed the experiments: OG UCTO CDOC JAN. Performed the experiments: CDOC HA AKR JAN. Analyzed the data: AKR JAN CDOC. Wrote the paper: CDOC JAN HJC RO OG.","The authors declare no competing interests. For full disclosure: This work was partly funded by the SGC, a registered charity (number 1097737) that receives funds from commercial entities (AbbVie, Bayer Pharma AG, Boehringer Ingelheim, GlaxoSmithKline, Janssen, Lilly Canada, Merck & Co., the Novartis Research Foundation, Pfizer and Takeda) as well as public funders (the Canada Foundation for Innovation, Genome Canada, the Ontario Ministry of Economic Development and Innovation, São Paulo Research Foundation-FAPESP, and the Wellcome Trust [092809/Z/10/Z]). All research results and reagents are placed in the public domain without patents. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.","2016","02","Joseph A Newman","JAN",8,FALSE,4,4,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
